• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生长分化因子 15:炎症与心血管疾病之间的联系。

Growth and differentiation factor-15: A link between inflammaging and cardiovascular disease.

机构信息

Heart and Vascular Center, Semmelweis University, Városmajor utca 68, Budapest H-1122, Hungary.

Department of Genetics, Cell- and Immunobiology, Semmelweis University, Nagyvárad tér 4, Budapest H-1089, Hungary.

出版信息

Biomed Pharmacother. 2024 May;174:116475. doi: 10.1016/j.biopha.2024.116475. Epub 2024 Mar 24.

DOI:10.1016/j.biopha.2024.116475
PMID:38522236
Abstract

Age-related disorders are closely linked to the accumulation of senescent cells. The senescence-associated secretory phenotype (SASP) sustains and progresses chronic inflammation, which is involved in cellular and tissue dysfunction. SASP-related growth and differentiation factor-15 (GDF-15) is an immunoregulatory cytokine that is coupled to aging and thus may have a regulatory role in the development and maintenance of atherosclerosis, a major cause of cardiovascular disease (CVD). Although the effects of GDF-15 are tissue-specific and dependent on microenvironmental changes such as inflammation, available data suggest that GDF-15 has a significant role in CVD. Thus, GDF-15 is a promising biomarker and potential therapeutic target for atherosclerotic CVD.

摘要

与年龄相关的疾病与衰老细胞的积累密切相关。衰老相关分泌表型(SASP)维持并促进慢性炎症,而慢性炎症与细胞和组织功能障碍有关。SASP 相关的生长和分化因子-15(GDF-15)是一种免疫调节细胞因子,与衰老有关,因此可能在动脉粥样硬化(CVD 的主要病因)的发生和维持中起调节作用。尽管 GDF-15 的作用具有组织特异性,并取决于炎症等微环境变化,但现有数据表明,GDF-15 在 CVD 中具有重要作用。因此,GDF-15 是动脉粥样硬化性 CVD 的有前途的生物标志物和潜在治疗靶点。

相似文献

1
Growth and differentiation factor-15: A link between inflammaging and cardiovascular disease.生长分化因子 15:炎症与心血管疾病之间的联系。
Biomed Pharmacother. 2024 May;174:116475. doi: 10.1016/j.biopha.2024.116475. Epub 2024 Mar 24.
2
[Senescence-associated secretory phenotype and inflammaging: the role in cardiovascular diseases.].[衰老相关分泌表型与炎症衰老:在心血管疾病中的作用。]
Adv Gerontol. 2022;35(5):737-746.
3
Proteomic Analysis of the Senescence-Associated Secretory Phenotype: GDF-15, IGFBP-2, and Cystatin-C Are Associated With Multiple Aging Traits.衰老相关分泌表型的蛋白质组学分析:GDF-15、IGFBP-2 和胱抑素 C 与多种衰老特征相关。
J Gerontol A Biol Sci Med Sci. 2024 Mar 1;79(3). doi: 10.1093/gerona/glad265.
4
Advances in relationship between cell senescence and atherosclerosis.细胞衰老与动脉粥样硬化关系的研究进展。
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2022 Feb 25;51(1):95-101. doi: 10.3724/zdxbyxb-2021-0270.
5
The role of cardiomyocyte senescence in cardiovascular diseases: A molecular biology update.心肌细胞衰老在心血管疾病中的作用:分子生物学研究进展。
Eur J Pharmacol. 2024 Nov 15;983:176961. doi: 10.1016/j.ejphar.2024.176961. Epub 2024 Aug 28.
6
Senescence-Associated Secretory Phenotype of Cardiovascular System Cells and Inflammaging: Perspectives of Peptide Regulation.心血管系统细胞衰老相关分泌表型和炎老化:肽调节的视角。
Cells. 2022 Dec 27;12(1):106. doi: 10.3390/cells12010106.
7
The potential of flavonoids to mitigate cellular senescence in cardiovascular disease.类黄酮减轻心血管疾病中细胞衰老的潜力。
Biogerontology. 2024 Nov;25(6):985-1010. doi: 10.1007/s10522-024-10141-7. Epub 2024 Sep 26.
8
Cellular senescence links aging and diabetes in cardiovascular disease.细胞衰老将衰老和糖尿病与心血管疾病联系起来。
Am J Physiol Heart Circ Physiol. 2018 Sep 1;315(3):H448-H462. doi: 10.1152/ajpheart.00287.2018. Epub 2018 May 11.
9
Cellular Senescence and Inflammaging in the Bone: Pathways, Genetics, Anti-Aging Strategies and Interventions.细胞衰老与骨内炎症:途径、遗传学、抗衰老策略与干预。
Int J Mol Sci. 2024 Jul 5;25(13):7411. doi: 10.3390/ijms25137411.
10
Senescence and senolysis in cancer: The latest findings.衰老和衰老细胞清除在癌症中的作用:最新研究发现。
Cancer Sci. 2024 Jul;115(7):2107-2116. doi: 10.1111/cas.16184. Epub 2024 Apr 19.

引用本文的文献

1
Evolving tumor microenvironment: Driving cancer initiation and progression in cardiovascular diseases.不断演变的肿瘤微环境:推动心血管疾病中的癌症发生与进展
iScience. 2025 Aug 18;28(9):113387. doi: 10.1016/j.isci.2025.113387. eCollection 2025 Sep 19.
2
New and Emerging Biomarkers in Chronic Kidney Disease.慢性肾脏病中的新型和新兴生物标志物
Biomedicines. 2025 Jun 10;13(6):1423. doi: 10.3390/biomedicines13061423.
3
Serum growth differentiation factor 15 associates with extra-glandular manifestations and disease activity of primary Sjögren's syndrome.
血清生长分化因子15与原发性干燥综合征的腺外表现及疾病活动相关。
Sci Rep. 2025 Jun 6;15(1):20007. doi: 10.1038/s41598-025-03698-x.
4
Soluble urokinase plasminogen activator receptor (suPAR) as a prognostic biomarker in acutely admitted patients with atrial fibrillation.可溶性尿激酶型纤溶酶原激活物受体(suPAR)作为急性入院房颤患者的预后生物标志物。
J Arrhythm. 2025 Apr 23;41(2):e70077. doi: 10.1002/joa3.70077. eCollection 2025 Apr.
5
The composition of single-donor apheresis platelet concentrates is influenced by the age of the donor.单采血小板浓缩物的成分受献血者年龄的影响。
Sci Rep. 2025 Apr 18;15(1):13505. doi: 10.1038/s41598-025-97916-1.
6
Cardiovascular Biomarkers: Tools for Precision Diagnosis and Prognosis.心血管生物标志物:精准诊断与预后的工具
Int J Mol Sci. 2025 Mar 30;26(7):3218. doi: 10.3390/ijms26073218.
7
The global burden and biomarkers of cardiovascular disease attributable to ambient particulate matter pollution.环境细颗粒物污染所致心血管疾病的全球负担及生物标志物
J Transl Med. 2025 Mar 22;23(1):359. doi: 10.1186/s12967-025-06375-9.
8
Palmitate potentiates the SMAD3-PAI-1 pathway by reducing nuclear GDF15 levels.棕榈酸盐通过降低细胞核中生长分化因子15(GDF15)的水平来增强SMAD3-纤溶酶原激活物抑制剂1(PAI-1)信号通路。
Cell Mol Life Sci. 2025 Jan 18;82(1):43. doi: 10.1007/s00018-024-05571-y.
9
Mechanisms Underlying Vascular Inflammaging: Current Insights and Potential Treatment Approaches.血管炎症衰老的潜在机制:当前见解与潜在治疗方法
Aging Dis. 2024 Oct 18;16(4):1889-1917. doi: 10.14336/AD.2024.0922.
10
Circulating level of growth-differentiation factor 15 and the functional outcome after acute ischemic stroke: a systematic review and meta-analysis.生长分化因子15的循环水平与急性缺血性中风后的功能结局:一项系统评价和荟萃分析。
Head Face Med. 2024 Dec 28;20(1):72. doi: 10.1186/s13005-024-00476-4.